Fuji Yakuhin Co., Ltd.November 25, 2022

FDA 483 - Fuji Yakuhin Co., Ltd. - November 25, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Fuji Yakuhin Co., Ltd.

Record Details

Fuji Yakuhin Co., Ltd. in Toyama-shi, Japan, a sterile drug manufacturer, was inspected by the FDA. The inspection revealed significant deficiencies in aseptic manufacturing practices, including improper operator techniques and inadequate airflow studies. Additionally, the firm failed to properly qualify equipment and retain samples of active drug substances.

Company: Fuji Yakuhin Co., Ltd.
Inspection Date: November 25, 2022
Product Type: Drugs
Office: Office of Biological Products Operations - Division I
Person: Robert J. Martin

Open in Dashboard

ID · 5b637290-938f-4705-abff-d1e01c51ea03